Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

NCT01974752 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic
Uveal Melanoma

Interventions

DRUG: 75mg selumetinib
DRUG: placebo
DRUG: Dacarbazine

Sponsor

AstraZeneca